Asset / Drug

Trial

Drug and asset intelligence for Trial with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 5
Catalysts: 0
Stage: Development stage unavailable

Mechanism of action

Radiation Therapy

Recent signals(5)

ClinicalJune 20, 2026

Trial on Mobile Health Platform to Improve Adherence in Metastatic Breast Cancer Patients

A clinical trial is assessing the effectiveness of the CONCURxP platform in improving medication adherence among metastatic breast cancer patients on CDK4/6 inhibitors.

ClinicalJune 20, 2026

Trial of SMS Platform to Prevent Malnutrition in HIV-Exposed Children in Kenya

A trial is underway to evaluate a two-way SMS platform aimed at improving nutritional outcomes for HIV-exposed children in Kenya.

ClinicalJune 13, 2026

Trial on MRI-guided SBRT for Liver Metastases Aims to Establish Safe Dose Levels

A clinical trial is underway to determine the maximum tolerated dose of MRI-guided SBRT for liver metastases.

ClinicalJune 12, 2026

Trial Compares Silicone Barrier Spray to Zinc Oxide for Incontinence-Associated Dermatitis

A randomized controlled trial is evaluating the effectiveness of silicone barrier spray versus zinc oxide ointment for mild incontinence-associated dermatitis.

ClinicalJune 11, 2026